Document is current
Any future updates will be listed below
-
Authors
Iachetta, Giuseppina
Melle, Giovanni
Colistra, Nicolò
Tantussi, Francesco
De Angelis, Francesco
Dipalo, Michele https://orcid.org/0000-0002-1823-8231
-
Funding
Funding for this research was provided by:
H2020 Future and Emerging Technologies (964518: TOX-Free)
Istituto Italiano di Tecnologia
- License Information
-
More Information
Article History
Received: 24 June 2022
Accepted: 15 November 2022
First Online: 6 January 2023
Declarations
:
: F.D.A. and M.D. are inventors of patent application WO2019116257A1, related to cell optoporation. F.D.A., M.D., F.T. and G.I. are shareholders of the Italian company FORESEE Biosystems srl, which works on cell optoporation systems. G.M. is chief executive officer (CEO), N.C. is Chief Technology Officer (CTO) and M.D. is Chief Strategy officer <b>(</b>CSO) of FORESEE Biosystems srl.
